A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design
- PMID: 9548494
A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design
Abstract
We have investigated the proliferative and Th cell responses to the Plasmodium chabaudi adami DS homologue of the Plasmodium falciparum apical membrane Ag 1 (AMA-1), a leading malaria vaccine candidate. Immunodominant T cell epitopes were defined following immunization of BALB/c mice with Escherichia coli-expressed, refolded P. c. adami DS AMA-1 recombinant protein and testing cells from the draining lymph nodes for responses against a series of overlapping peptides spanning P. c. adami AMA-1. A limited number of major T cell sites were identified in both conserved and variable regions of the protein. Several cryptic epitopes that evoked T cell responses following immunization with peptides, but not after protein immunization, were also identified. Adoptive transfer of a T cell line specific for a conserved cryptic epitope (corresponding to residues 31-50) provided help for an anti-AMA-1 protein-specific Ab response following in vivo challenge with P. c. adami parasitized RBC, such that AMA-1-specific Abs appeared more rapidly in recipient mice than in controls. Furthermore, T cells specific for cryptic epitopes afforded partial protection against P. c. adami infection in nude mice. The identification of conserved cryptic Th cell epitopes has important implications for malaria vaccine design.
Similar articles
-
A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.Infect Immun. 2004 Oct;72(10):5565-73. doi: 10.1128/IAI.72.10.5565-5573.2004. Infect Immun. 2004. PMID: 15385453 Free PMC article.
-
Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.Pept Res. 1990 May-Jun;3(3):110-5. Pept Res. 1990. PMID: 1724615
-
CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.J Immunol. 2000 Jul 1;165(1):389-96. doi: 10.4049/jimmunol.165.1.389. J Immunol. 2000. PMID: 10861076
-
[Achievements and problems in the development of malaria vaccines].Rev Latinoam Microbiol. 1993 Jul-Sep;35(3):319-25. Rev Latinoam Microbiol. 1993. PMID: 8047736 Review. Spanish.
-
Immunity to erythrocytic stages of malarial parasites.Am J Trop Med Hyg. 1994;50(4 Suppl):27-32. doi: 10.4269/ajtmh.1994.50.27. Am J Trop Med Hyg. 1994. PMID: 7909653 Review.
Cited by
-
Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.J Immunol. 2012 May 15;188(10):5041-53. doi: 10.4049/jimmunol.1101106. Epub 2012 Apr 13. J Immunol. 2012. PMID: 22504652 Free PMC article.
-
Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.Infect Immun. 2002 Dec;70(12):6961-7. doi: 10.1128/IAI.70.12.6961-6967.2002. Infect Immun. 2002. PMID: 12438375 Free PMC article.
-
Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial.Vaccine. 2009 Mar 26;27(15):2171-6. doi: 10.1016/j.vaccine.2009.01.097. Epub 2009 Jan 31. Vaccine. 2009. PMID: 19356621 Free PMC article. Clinical Trial.
-
Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.Infect Immun. 2013 Oct;81(10):3586-99. doi: 10.1128/IAI.00544-13. Epub 2013 Jul 8. Infect Immun. 2013. PMID: 23836827 Free PMC article.
-
Increasing the frequency of T-cell precursors specific for a cryptic epitope of hen-egg lysozyme converts it to an immunodominant epitope.Immunology. 2000 Feb;99(2):235-42. doi: 10.1046/j.1365-2567.2000.00968.x. Immunology. 2000. PMID: 10692042 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases